Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Sakar Healthcare Limited (NSE: SAKAR), ISIN INE732S01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SAKAR last traded at ₹1182.55 (+1.71%), with a 52-week range of ₹345.50 to ₹1229.85 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 52.52%, FIIs 12.13%, DIIs 11.37%, mutual funds 0.00%.
EquiSense Score (ECS): 78/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.